PUBLIC RELEASE: 28-JUL-2016 Full Article Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumor growth. Experts used an advanced screening technique which found hundreds of genes were affected by the male hormone testosterone. It is believed this could…
PUBLIC RELEASE: 28-JUL-2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Study reveals protein’s ability to block expression of metastasis-linked genes UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER PUBLIC RELEASE: 28-JUL-2016 Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at…
New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Active surveillance…
New York, NY, July 27, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study published in The Journal of Urology® ELSEVIER HEALTH SCIENCES Although active surveillance, or watchful waiting, for patients with low risk…
Date: July 11, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer my be an indolent condition…
By LANNIS HALL, ARNOLD D. BULLOCK, ANGELA L. BROWN and GRAHAM COLDITZJULY 27, 2016 [ultimate_spacer height=”32″]Full Article [ultimate_spacer height=”32″] St. Louis — In 1966, the Rev. Dr. Martin Luther King Jr. said, “Of all the forms of inequality, injustice in health care is the most shocking and inhuman.” While major advances have been made in…
July 10, 2016 Bryant Furlow [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.1“We are now entering an era of personalized prostate cancer therapy informed by treatment-specific biomarkers, some of which can be performed using a…
Natasha Persaud, Digital Content Editor July 14, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Swedish researchers have provided new estimates of the hereditary risk of significant prostate cancers (PCa) that may aid in patient counseling. Clinicians have long known that having a father or brother with PCa doubles a man’s risk for the disease, but many of these cancers…
14-Jul-2016 8:05 AM [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Newswise — BUFFALO, N.Y. — While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary treatment, the challenge for clinicians is to monitor and distinguish early-stage tumors from advanced cancers. A team of scientists led by researchers from Roswell Park Cancer Institute have…
Date:July 7, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations in genes involved in repairing DNA damage, a major new study reveals. Testing prostate cancer patients for mutations in key DNA repair genes could identify those…